FR177391, a new anti-hyperlipidemic agent from Serratia. III. Microbial conversion of FR177391 and synthesis of FR177391 derivatives for its target protein screening by chemical genetic approaches

J Antibiot (Tokyo). 2005 Oct;58(10):648-53. doi: 10.1038/ja.2005.89.

Abstract

FR177391 produced by Serratia liquefaciens No. 1821 enhances differentiation of mouse 3T3-L1 fibroblasts to adipocytes and reduces the circulating levels of triglyceride in C57BL/KsJ-db/bd mice, an obese non-insulin-dependent diabetes mellitus animal model, although its mechanism of actions remained to be unknown. Its active derivative, 20-hydroxy FR177391, and its inactive derivative, 3-hydroxy FR177391 were produced by microbial conversion of FR177391, and biotin-labeled FR177391 was synthesized from 20-hydroxy FR177391 as an active affinity ligand to identify target molecules of FR177391 by chemical genetic approaches.

MeSH terms

  • Hypolipidemic Agents / chemical synthesis
  • Hypolipidemic Agents / metabolism
  • Hypolipidemic Agents / pharmacology*
  • Magnetic Resonance Spectroscopy
  • Serratia / chemistry*

Substances

  • Hypolipidemic Agents